Bryan M. Reasons - Net Worth and Insider Trading
Bryan M. Reasons Net Worth
The estimated net worth of Bryan M. Reasons is at least $1 Million dollars as of 2024-08-25. Bryan M. Reasons is the CFO of Amneal Pharmaceuticals Inc and owns about 82,986 shares of Amneal Pharmaceuticals Inc (AMRX) stock worth over $695,423. Bryan M. Reasons is the Director of Societal CDMO Inc and owns about 291,049 shares of Societal CDMO Inc (SCTL) stock worth over $320,154. Bryan M. Reasons is also the EVP & CFO of Mallinckrodt PLC and owns about 11,593 shares of Mallinckrodt PLC (MNKKQ) stock worth over $232. Details can be seen in Bryan M. Reasons's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bryan M. Reasons has not made any transactions after 2023-08-28 and currently still holds the listed stock(s).
Transaction Summary of Bryan M. Reasons
Bryan M. Reasons Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bryan M. Reasons owns 5 companies in total, including Aclaris Therapeutics Inc (ACRS) , Societal CDMO Inc (SCTL) , and Mallinckrodt PLC (MNKKQ) among others .
Click here to see the complete history of Bryan M. Reasons’s form 4 insider trades.
Insider Ownership Summary of Bryan M. Reasons
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ACRS | Aclaris Therapeutics Inc | 2018-04-20 | director |
SCTL | Societal CDMO Inc | 2023-08-28 | director |
MNKKQ | Mallinckrodt PLC | 2022-06-16 | EVP & CFO |
![]() | ![]() | 2018-08-21 | CFO |
![]() | ![]() | 2022-06-16 | EVP & CFO |
Bryan M. Reasons Latest Holdings Summary
Bryan M. Reasons currently owns a total of 3 stocks. Among these stocks, Bryan M. Reasons owns 82,986 shares of Amneal Pharmaceuticals Inc (AMRX) as of August 21, 2018, with a value of $695,423 and a weighting of 68.46%. Bryan M. Reasons owns 291,049 shares of Societal CDMO Inc (SCTL) as of August 28, 2023, with a value of $320,154 and a weighting of 31.52%. Bryan M. Reasons also owns 11,593 shares of Mallinckrodt PLC (MNKKQ) as of December 3, 2020, with a value of $232 and a weighting of 0.02%.
Latest Holdings of Bryan M. Reasons
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMRX | Amneal Pharmaceuticals Inc | 2018-08-21 | 82,986 | 8.38 | 695,423 |
SCTL | Societal CDMO Inc | 2023-08-28 | 291,049 | 1.10 | 320,154 |
MNKKQ | Mallinckrodt PLC | 2020-12-03 | 11,593 | 0.02 | 232 |
Holding Weightings of Bryan M. Reasons
Bryan M. Reasons Form 4 Trading Tracker
According to the SEC Form 4 filings, Bryan M. Reasons has made a total of 0 transactions in Amneal Pharmaceuticals Inc (AMRX) over the past 5 years. The most-recent trade in Amneal Pharmaceuticals Inc is the sale of 11,698 shares on August 21, 2018, which brought Bryan M. Reasons around $276,658.
According to the SEC Form 4 filings, Bryan M. Reasons has made a total of 1 transactions in Societal CDMO Inc (SCTL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Societal CDMO Inc is the acquisition of 62,500 shares on August 28, 2023, which cost Bryan M. Reasons around $25,000.
According to the SEC Form 4 filings, Bryan M. Reasons has made a total of 1 transactions in Mallinckrodt PLC (MNKKQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Mallinckrodt PLC is the sale of 5,400 shares on December 3, 2020, which brought Bryan M. Reasons around $918.
Insider Trading History of Bryan M. Reasons
- 1
Bryan M. Reasons Trading Performance
GuruFocus tracks the stock performance after each of Bryan M. Reasons's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryan M. Reasons is -46.57%. GuruFocus also compares Bryan M. Reasons's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryan M. Reasons within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bryan M. Reasons's insider trading performs compared to the benchmark.
Performance of Bryan M. Reasons
Bryan M. Reasons Ownership Network
Ownership Network List of Bryan M. Reasons
Ownership Network Relation of Bryan M. Reasons
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Bryan M. Reasons Owned Company Details
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Bryan M. Reasons is the director of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Bryan M. Reasons made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 48,837 shares made by Joseph Monahan , and a net purchase of 12,800 shares made by Douglas J. Manion .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 4,854,052 shares, with a net purchase of 4,854,052 shares. During the past 18 months, 109,971 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,891,047 shares were bought by its insiders, resulting in a net purchase of 4,781,076 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
Bryan M. Reasons Mailing Address
Above is the net worth, insider trading, and ownership report for Bryan M. Reasons. You might contact Bryan M. Reasons via mailing address: C/o Impax Laboratories, Inc., 30831 Huntwood Avenue, Hayward Ca 94544.